These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25749047)

  • 1. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.
    Burks J; Reed RE; Desai SD
    Oncotarget; 2015 Mar; 6(9):7221-31. PubMed ID: 25749047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
    Burks J; Reed RE; Desai SD
    Oncogene; 2014 Feb; 33(6):794-803. PubMed ID: 23318454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.
    Desai SD; Reed RE; Burks J; Wood LM; Pullikuth AK; Haas AL; Liu LF; Breslin JW; Meiners S; Sankar S
    Exp Biol Med (Maywood); 2012 Jan; 237(1):38-49. PubMed ID: 22185919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.
    Desai SD; Haas AL; Wood LM; Tsai YC; Pestka S; Rubin EH; Saleem A; Nur-E-Kamal A; Liu LF
    Cancer Res; 2006 Jan; 66(2):921-8. PubMed ID: 16424026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein ISGylation and free ISG15 levels are increased by interferon gamma in breast cancer cells.
    Tecalco-Cruz AC; Cruz-Ramos E
    Biochem Biophys Res Commun; 2018 May; 499(4):973-978. PubMed ID: 29626479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation.
    Held T; Basler M; Knobeloch KP; Groettrup M
    Eur J Immunol; 2021 Jan; 51(1):138-150. PubMed ID: 32686110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
    Bektas N; Noetzel E; Veeck J; Press MF; Kristiansen G; Naami A; Hartmann A; Dimmler A; Beckmann MW; Knüchel R; Fasching PA; Dahl E
    Breast Cancer Res; 2008; 10(4):R58. PubMed ID: 18627608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis.
    Fan JB; Arimoto K; Motamedchaboki K; Yan M; Wolf DA; Zhang DE
    Sci Rep; 2015 Jul; 5():12704. PubMed ID: 26226047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between interferon-stimulated gene 15/ISGylation and interferon gamma signaling in breast cancer cells.
    Tecalco-Cruz AC; Cortés-González CC; Cruz-Ramos E; Ramírez Jarquín JO; Romero-Mandujano AK; Sosa-Garrocho M
    Cell Signal; 2019 Feb; 54():91-101. PubMed ID: 30500379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.
    Zou W; Wang J; Zhang DE
    Biochem Biophys Res Commun; 2007 Mar; 354(1):321-7. PubMed ID: 17222803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Functional Roles of ISG15/ISGylation in Cancer.
    Yuan Y; Qin H; Li H; Shi W; Bao L; Xu S; Yin J; Zheng L
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36771004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.
    Yoo L; Yoon AR; Yun CO; Chung KC
    Cell Death Dis; 2018 Jan; 9(2):97. PubMed ID: 29367604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and action of interferon-stimulated gene 15 in breast cancer cells.
    Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
    Hum Cell; 2020 Oct; 33(4):954-962. PubMed ID: 32813218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ISG15 as a novel tumor biomarker for drug sensitivity.
    Desai SD; Wood LM; Tsai YC; Hsieh TS; Marks JR; Scott GL; Giovanella BC; Liu LF
    Mol Cancer Ther; 2008 Jun; 7(6):1430-9. PubMed ID: 18566215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.
    Zuo C; Sheng X; Ma M; Xia M; Ouyang L
    Oncotarget; 2016 Nov; 7(45):74393-74409. PubMed ID: 27626310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-muscle myosin IIA is post-translationally modified by interferon-stimulated gene 15 in breast cancer cells.
    Cruz-Ramos E; Macías-Silva M; Sandoval-Hernández A; Tecalco-Cruz AC
    Int J Biochem Cell Biol; 2019 Feb; 107():14-26. PubMed ID: 30529400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation.
    Yeh YH; Yang YC; Hsieh MY; Yeh YC; Li TK
    Clin Cancer Res; 2013 Nov; 19(21):5927-39. PubMed ID: 24056783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISG15 in cancer: Beyond ubiquitin-like protein.
    Han HG; Moon HW; Jeon YJ
    Cancer Lett; 2018 Dec; 438():52-62. PubMed ID: 30213559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
    Brown AR; Simmen RC; Raj VR; Van TT; MacLeod SL; Simmen FA
    Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
    Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
    Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.